Holen Sie sich die Stockscreener-App
22.21
0.13%
-0.03
Handel nachbörslich:
22.21
Innoviva Inc Aktie (INVA) Neueste Nachrichten
Innoviva to Participate in Upcoming Investor Conferences - AOL.com
How Innoviva Inc. (INVA) Affects Rotational Strategy Timing - Stock Traders Daily
Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap? - simplywall.st
Innoviva Inc (NASDAQ:INVA): A Decent Value Play with Strong Fundamentals - ChartMill
Enterprise value to EBITDA forward of Innoviva, Inc. – SWB:HVE - TradingView
Price to sales forward of Innoviva, Inc. – SWB:HVE - TradingView
Innoviva Inc. (INVA) Sees Modest Uptick, Testing Resistance Near $23.43Safe Entry Stocks - dars.gov.et
INVAInnoviva Inc Latest SEC Filings - Finviz
Is Innoviva (INVA) Trading Index Membership for a Deeper Bet on Nortiva Bio’s LYNX Platform? - simplywall.st
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now? - Insider Monkey
5 Cheap Small Cap Stocks to Buy Now - Insider Monkey
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Is Innoviva (INVA) Undervalued After Nortiva Bio Launch And XACDURO Deal? - Sahm
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 2000 Growth-Defensive Index - marketscreener.com
Innoviva, Inc.(NasdaqGS: INVA) dropped from Russell 3000 Growth Benchmark - marketscreener.com
INVA Forecast — Price Target — Prediction for 2027 - TradingView
How Investors Are Reacting To Innoviva (INVA) Expanding Drug Delivery Tech And XACDURO Global Partnership - Sahm
Enterprise value to EBIT forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
INNOVIVA INC (NASDAQ:INVA): A Strong Growth Stock Poised for a Technical Breakout - ChartMill
Price to earnings forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
(INVA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Price to book forward of Innoviva, Inc. – NASDAQ:INVA - TradingView
Enterprise value to revenue forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (NASDAQ:INVA) - TradingView
Innoviva, Inc. Actuals & Estimates (DUS:HVE) - TradingView
HVE Forecast — Price Target — Prediction for 2027 - TradingView
Innoviva Inc (INVA) Institutional Confidence - TradingKey
Has Innoviva Successfully Pivoted Beyond its Royalty Roots - Kavout | AI
Price to sales forward of Innoviva, Inc. – GETTEX:HVE - TradingView
Innoviva, Inc. Actuals & Estimates (SWB:HVE) - TradingView
Innoviva, Inc. Actuals & Estimates (LS:A2AC9U) - TradingView
A2AC9U Forecast — Price Target — Prediction for 2027 - TradingView
Innoviva, Inc. (INVA) Launches Nortiva Bio to Advance Long-Acting Oral Drug Platform - Insider Monkey
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42 - Moomoo
Innoviva Inc (INVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Innoviva Specialty Therapeutics (INVA) Partners With Dr. Reddy’s to Expand XACDURO Access Internationally - Insider Monkey
INVA Maintained by BTIG -- Price Target Steady at $42.00 - GuruFocus
H.C. Wainwright Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $46 - Moomoo
Innoviva Is Maintained at Buy by BTIG - Moomoo
H.C. Wainwright reiterates Innoviva stock rating on drug delivery platform By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Innoviva stock rating on drug delivery platform - Investing.com
Innoviva stock trades down to $22.49 as Western Thoracic conference focus draws attention - Traders Union
Innoviva stock trades down to $22.49 as company highlights role of ATC2026 in transplant research - Traders Union
Will XACDURO Licensing Deal With Dr. Reddy’s Reshape Innoviva’s (INVA) Infectious Disease Strategy? - simplywall.st
5.60%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):